Oxford-AstraZeneca Covid-19 vaccine helps UK lead race to reach nursing homes



[ad_1]

LONDON – The coronavirus has ravaged nursing homes in the UK, as it has in the US, killing tens of thousands. Now the UK hopes to turn the tide with a local vaccine that has yet to be licensed elsewhere in the West.

More than four million of those most at risk in the UK, nearly 8% of the adult population, have been vaccinated with at least one shot of the vaccine.

Among them, more than half of the most fragile group of all: the 300,000 elderly people living in nursing homes who cannot travel to get vaccinated. The key to reaching them has been mobile vaccination teams armed with a vaccine developed by the University of Oxford and AstraZeneca PLC.

Paired with a network of family doctors and vaccination centers in sports centers, hotels and cathedrals, this shot has helped the country stay on track towards the goal of vaccinating its 15 million most vulnerable people. by mid-February.

The government says the AstraZeneca vaccine, which has also been licensed in India, Morocco and some countries in Latin America, has been a game-changer by reaching people tucked away in smaller nursing homes.

[ad_2]

Source link